Diffusion MRI in Cervical Spondylotic Myelopathy

Status Enrolling by invitation

Clinical Trial Summary

diffusion MRI in evaluates and predicts prognosis in CSM

Clinical Trial Description

Cervical spondylotic myelopathy (CSM) is a spinal dysfunction disease common in the elderly population caused by cervical spine degeneration, spinal canal stenosis, and spinal cord compression. It may result in reduced quality of life or even disability. With the increased life expectancy of today's population, the incidence of CSM is increasing. Surgery is recommended to reduce compression of the spinal cord. However, due to individual differences and variations in spinal cord injury severity, the prognosis after surgery is often unpredictable. Therefore, proper evaluation of spinal cord function and prognosis prediction are important considerations for the clinical decision of whether to operate and selection of appropriate operation time. To achieve this goal, medical images are used to correctly evaluate the damage and recovery potential of neurons. Magnetic resonance imaging (MRI) provides spinal cord macrostructure details and can detect spinal cord damage. Clinically, conventional MRI is often used to confirm a CSM diagnosis and predict prognosis. However, MRI assessments, including increased signal intensity (ISI) and T1 hypo-intensity, might not be consistent with clinical manifestations or prognostic expectations. Diffusion MRI (dMRI) enables early diagnoses and prognostic predictions due to its microstructure assessment advantages. The diffusion of water molecules is restricted due to structural barriers, such as axon membranes and myelin sheaths. Using the microscopic movement of water molecules, dMRI can detect microstructures indirectly using a model with specific underlying probability distribution function of diffusion. Three models are widely applied clinically: diffusion tensor imaging (DTI), diffusional kurtosis imaging (DKI), and neurite orientation dispersion and density imaging (NODDI). DTI assumes the diffusion distribution function to be Gaussian, DKI assumes it to be non-Gaussian, and NODDI assumes it to be multi-compartmental (intracellular pool, extracellular pool, and free water). Previous studies suggested the potential application value of DTI and DKI in patients with CSM; however, these models had limited specificity and were not sufficient to diagnose CSM in a clinical setting. Compared with DTI and DKI, NODDI has been shown to characterize spinal cord microstructure better. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04952831
Study type	Observational
Source	Peking University Third Hospital
Contact
Status	Enrolling by invitation
Phase
Start date	September 1, 2020
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00565734` - Surgical Treatment of Cervical Spondylotic Myelopathy	Phase 4
Completed	`NCT00506558` - The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy	Phase 3
Recruiting	`NCT00876603` - Anterior Vs Posterior Procedures for Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial	N/A
Recruiting	`NCT06377072` - Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy	Phase 3
Enrolling by invitation	`NCT03513679` - Gait in Adult Patients With Cervical Spondylotic Myelopathy	N/A
Completed	`NCT01257828` - Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)	Phase 3
Completed	`NCT04968054` - Comparison of IONM Between Remimazolam and Propofol	N/A
Active, not recruiting	`NCT03296592` - Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
Active, not recruiting	`NCT04955041` - Effectiveness of T2* MRI in Cervical Spondylotic Myelopathy
Completed	`NCT01061697` - Pregabalin and Radicular Pain Study (PARPS)	Phase 4
Completed	`NCT03810781` - Postural Stability in Cervical Spinal Myelopathy
Recruiting	`NCT04936074` - Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy	N/A
Completed	`NCT00285337` - Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy	N/A
Completed	`NCT02539394` - Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion	N/A
Recruiting	`NCT05149404` - The Application of Enhanced Recovery After Surgery Clinical Pathway in Posterior Cervical Spine Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.